Capecitabine

ANTI-CPT2 CLONE 1G7 ZOOMAB« RABBIT MONOCLONAL

ANTI-CPT2 CLONE 1G7 ZOOMAB« RABBIT MONOCLONAL

ANTI-SCD CLONE 2C2 ZOOMAB« RABBIT MONOCLONAL

ANTI-SCD CLONE 2C2 ZOOMAB« RABBIT MONOCLONAL

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Application Capecitabine has been used: in combination with gemcitabine to achieve glutamine deprivation by enhancing the sensitivity of expression in pancreatic ductal adenocarcinoma (PDAC) cells to inhibitors of glutamine metabolism and study

Application Capecitabine has been used: in combination with gemcitabine to achieve glutamine deprivation by enhancing the sensitivity of expression in pancreatic ductal adenocarcinoma (PDAC) cells to inhibitors of glutamine metabolism and study

Capecitabine is a tumor-selective fluoropyrimidine carbamate which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU.An antiproliferative 5-fluorouracil releasing compound.

Capecitabine is a tumor-selective fluoropyrimidine carbamate which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU.An antiproliferative 5-fluorouracil releasing compound.

Capecitabine is a tumor-selective fluoropyrimidine carbamate which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU.An antiproliferative 5-fluorouracil releasing compound.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the